Illumina, Inc. announced a new spatial technology programme that will empower researchers to map complex tissues and understand cellular behaviour at an unprecedented scale. Enabled on Illumina ...

A new spatial transcriptomic technology captures RNA patterns without requiring expensive imaging ...

SAN JOSE, Calif., March 25, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has entered a ...

We combine advanced technologies such as spatial transcriptomics, multiplexed imaging, and in situ sequencing to map cellular components in their native tissue context. Obtain high-resolution data ...

"Spatial transcriptomics opens entirely new pathways to gain crucial insight into the cellular function of organisms," said Steve Barnard, PhD, chief technology officer of Illumina. "Illumina spatial ...

Spatial transcriptomics is a technique that provides information about gene expression patterns within intact tissues. This technology employs various methodologies, including in situ sequencing (ISS) ...

New capabilities mark continued momentum as company advances discovery research applications and accelerates the global growth of its spatial biology business SAN JOSE, Calif., October 08, ...

Spatial ribonucleic acid (RNA) transcriptomics measures gene expression while preserving each molecule’s coordinates in intact tissue, tying transcripts to histology and local microenvironments.

Breast cancer remains a leading cause of cancer-related deaths globally, with triple-negative breast cancer (TNBC) presenting particular therapeutic challenges due to its aggressive nature and limited ...